Brain region ranking for 18FDG-PET computer-aided diagnosis of Alzheimer's disease

Classifying Cognitive Normal and Early Mild Cognitive Impairment of Alzheimer’s Disease by Applying Restricted Boltzmann Machine to fMRI Data

Background:

Neuroimaging is an important tool in early detection of Alzheimer’s disease (AD), which is a serious neurodegenerative brain disease among the elderly subjects. Independent component analysis (ICA) is arguably one of the most widely used algorithm for the analysis of brain imaging data, which can be used to extract intrinsic networks of brain from functional magnetic resonance imaging (fMRI).

Method:

Witnessed by recent studies, a more flexible model known as restricted Boltzmann machine (RBM) can also be used to extract spatial maps and time courses of intrinsic networks from resting state fMRI, moreover, RBM shows superior temporal features than ICA. Here, we seek to employ RBM to improve the performance of classifying individuals. Experiments are performed on healthy controls and subjects at the early stage of AD, i.e., cognitive normal (CN) and early mild cognitive impairment participants (EMCI), and two types of data, i.e., structural magnetic resonance imaging (sMRI) and fMRI data.

Results:

(1) By separately employing ICA for sMRI and fMRI, the features extracted from fMRI improve classification accuracy by 7.5% for CN and EMCI; (2) instead of applying ICA to fMRI, using RBM further improves classification accuracy by 7.75% for CN and EMCI; (3) the lesions at the early stage of AD are more likely to occur in the regions around slices 4, 6, 10, 14, 19, 51 and 59 of the whole brain in the longitudinal direction.

Conclusion:

By using fMRI instead of sMRI and RBM instead of ICA, we can classify CN and EMCI more efficiently.

Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by 18F-FDG Brain PET Imaging

Alzheimer's Disease (AD), one of the main causes of death in elderly people, is characterized by Mild Cognitive Impairment (MCI) at prodromal stage. Nevertheless, only part of MCI subjects could progress to AD. The main objective of this paper is thus to identify those who will develop a dementia of AD type among MCI patients. ¹⁸F-FluoroDeoxyGlucose Positron Emission Tomography (¹⁸F-FDG PET) serves as a neuroimaging modality for early diagnosis as it can reflect neural activity via measuring glucose uptake at resting-state. In this paper, we design a deep network on ¹⁸F-FDG PET modality to address the problem of AD identification at early MCI stage. To this end, a Multi-view Separable Pyramid Network (MiSePyNet) is proposed, in which representations are learned from axial, coronal and sagittal views of PET scans so as to offer complementary information and then combined to make a decision jointly. Different from the widely and naturally used 3D convolution operations for 3D images, the proposed architecture is deployed with separable convolution from slice-wise to spatial-wise successively, which can retain the spatial information and reduce training parameters compared to 2D and 3D networks, respectively. Experiments on ADNI dataset show that the proposed method can yield better performance than both traditional and deep learning-based algorithms for predicting the progression of Mild Cognitive Impairment, with a classification accuracy of 83.05%.

The Residual Center of Mass: An Image Descriptor for the Diagnosis of Alzheimer Disease

A crucial quest in neuroimaging is the discovery of image features (biomarkers) associated with neurodegenerative disorders. Recent works show that such biomarkers can be obtained by image analysis techniques. However, these techniques cannot be directly compared since they use different databases and validation protocols. In this paper, we present an extensive study of image descriptors for the diagnosis of Alzheimer Disease (AD) and introduce a new one, named Residual Center of Mass (RCM). The RCM descriptor explores image moments and other techniques to enhance brain regions and select discriminative features for the diagnosis of AD. For validation, a Support Vector Machine (SVM) is trained with the selected features to classify images from normal subjects and patients with AD. We show that RCM with SVM achieves the best accuracies on a considerable number of exams by 10-fold cross-validation - 95.1% on 507 FDG-PET scans and 90.3% on 1374 MRI scans.

Multilevel Feature Representation of FDG-PET Brain Images for Diagnosing Alzheimer's Disease

Using a single imaging modality to diagnose Alzheimer's disease (AD) or mild cognitive impairment (MCI) is a challenging task. FluoroDeoxyGlucose Positron Emission Tomography (FDG-PET) is an important and effective modality used for that purpose. In this paper, we develop a novel method by using single modality (FDG-PET) but multilevel feature, which considers both region properties and connectivities between regions to classify AD or MCI from normal control. First, three levels of features are extracted: statistical, connectivity, and graph-based features. Then, the connectivity features are decomposed into three different sets of features according to a proposed similarity-driven ranking method, which can not only reduce the feature dimension but also increase the classifier's diversity. Last, after feeding the three levels of features to different classifiers, a new classifier selection strategy, maximum Mean squared Error (mMsE), is developed to select a pair of classifiers with high diversity. In order to do the majority voting, a decision-making scheme, a nested cross validation technique is applied to choose another classifier according to the accuracy. Experiments on Alzheimer's Disease Neuroimaging Initiative database show that the proposed method outperforms most FDG-PET-based classification algorithms, especially for classifying progressive MCI (pMCI) from stable MCI (sMCI).